Drug-Price Probe Sends Pharma Shares Lower
Pharmaceutical shares fell after a new U.S. drug-price probe, but the available reporting does not identify its scope or show how it may affect patients.
Pharmaceutical shares fell after a new U.S. drug-price probe, but the available reporting does not identify its scope or show how it may affect patients.
Jeff Bezos has cited Austin as an example of housing policy that can encourage construction, but available reports do not establish which measures produced what results.
A federal push for a disputed New York gas pipeline and Nigeria’s review of gas licences and fuel reserves put energy security’s costs and benefits in focus.
The FTC’s Second Request extends its review of the proposed MiMedx-Sanara MedTech merger, while a senior Justice Department official says antitrust prosecutors remain ready to litigate.
California’s new transit-oriented housing law and a crowded slate of state ballot measures put zoning, development and affordability policy before voters and local governments.
Recent headlines offer no verified figures on wages, hiring or workforce participation, while reported AI safety incidents raise questions about oversight—not proven job losses.
A scan of recent headlines found no verified reports of food recalls, water contamination, farm conditions or EPA action.
A Texas application-fee waiver and data-center permitting pause, Florida’s governor’s race and New Jersey’s registration deadline show how state decisions shape access, infrastructure and elections.
Reports from Jigawa and Keralam show how fuel access and environmental zoning decisions can directly affect farmers, while key details and official responses remain unresolved.